Articles |

Idiopathic Pulmonary Fibrosis and Cyclosporine : A Lesson From Single-Lung Transplantation FREE TO VIEW

She S. Lok; Elaine Smith; Helen M. Doran; Richard Sawyer; Nizar Yonan; James J. Egan
Author and Funding Information

Affiliations: From the North West Lung Centre, Wythenshawe Hospital, Manchester, United Kingdom,  From the Pathology Department, Wythenshawe Hospital, Manchester, United Kingdom,  From the Radiology Department, Wythenshawe Hospital, Manchester, United Kingdom,  From the Transplant Unit, Wythenshawe Hospital, Manchester, United Kingdom

James J. Egan, MD, North West Regional Lung Centre, Wythenshawe Hospital, Southmoor Road, Manchester, United Kingdom, M23 9LT; e-mail: JJGEgan@aol.com

1998 by the American College of Chest Physicians

Chest. 1998;114(5):1478-1481. doi:10.1378/chest.114.5.1478
Text Size: A A A
Published online


Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and therapeutic options are limited with a 5-year survival of less than 50%. This report includes a case of histologically confirmed IPF in a patient whose native lung showed objective improvement as measured by high-resolution CT while he was receiving cyclosporine-based immunosuppressive therapy after single-lung transplantation.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543